{
    "nct_id": "NCT06419634",
    "official_title": "Phase I Multicenter, Open-Label, First-in-Human Study of BMS-986497 (ORM-6151) in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome",
    "inclusion_criteria": "* Adults with primary or secondary relapsed and/or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).\n* Detectable levels of cluster of differentiation 33 (CD33) expression.\n* Failed alternative therapies with established benefit.\n* Eastern Cooperative Oncology Group (ECOG) performance status â‰¤2 and adequate organ function.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Acute Promyelocytic Leukemia.\n* Clinically active central nervous system leukemia.\n* Active malignant solid tumor.\n* Pregnant or breastfeeding.\n* Other protocol-defined inclusion/exclusion criteria apply.",
    "miscellaneous_criteria": ""
}